Home / Inspections / 1180157

FDA Inspection 1180157 — Towa Pharmaceutical Europe, S.L.

Towa Pharmaceutical Europe, S.L. — FEI 3003121577

The FDA completed an inspection of Towa Pharmaceutical Europe, S.L. on September 9, 2022 in Martorelles. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 9, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Martorelles (Spain)

Facility

Other inspections at this facility

  • 1100280 (NAI Fri Jan 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1018727 (VAI Fri Mar 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 917425 (VAI Fri Feb 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 835225 (NAI Fri May 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 658164 (NAI Fri Feb 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources